Dynamic Technology Lab’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Dynamic Technology Lab’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,891	Closed	-$112K	–	1529
2018 Q2	$112K	Buy	28,891 +15,931	+123%	+$106K	0.02%	894
2018 Q1	$82K	Buy	+12,960	New	+$107K	0.01%	978
2017 Q3	–	Sell	-2,706	Closed	-$27K	–	1563
2017 Q2	$27K	Buy	+2,706	New	+$55.3K	0.01%	968
2016 Q3	–	Sell	-1,343	Closed	-$56K	–	1328
2016 Q2	$56K	Buy	+1,343	New	+$73.2K	0.02%	813
2014 Q4	–	Sell	-3,228	Closed	-$222K	–	987
2014 Q3	$222K	Buy	+3,228	New	+$172K	0.11%	457

Other funds holding MACK

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Dynamic Technology Lab's MACK Position: Q3 2018 in Review

Dynamic Technology Lab sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2018, closing a stake of 28,891 shares — an estimated $112K sold.

Dynamic Technology Lab first reported a position in MACK in Q3 2014 and held it in 5 quarters. The position peaked at $222K in Q3 2014. 63 funds tracked by Wall St. Rank hold MACK as of Q3 2018.

Dynamic Technology Lab reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Dynamic Technology Lab sold 28,891 Merrimack Pharmaceuticals, Inc. shares in Q3 2018, an estimated $112K.
Dynamic Technology Lab first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2014 and held it in 5 quarters.
Dynamic Technology Lab's Merrimack Pharmaceuticals, Inc. position peaked at $222K in Q3 2014.
63 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2018.

Based on Dynamic Technology Lab's 13F filing for Q3 2018, filed 14 Nov 2018.